Literature DB >> 12238934

Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies.

Susan R Doctrow1, Karl Huffman, Catherine Bucay Marcus, Georges Tocco, Evelyne Malfroy, Christy A Adinolfi, Henry Kruk, Keith Baker, Natalie Lazarowych, Julius Mascarenhas, Bernard Malfroy.   

Abstract

Synthetic catalytic scavengers of reactive oxygen species (ROS) may have broad clinical applicability. In previous papers, two salen-manganese complexes, EUK-8 and EUK-134, had superoxide dismutase (SOD) and catalase activities and prevented ROS-associated tissue injury. This study describes two series of salen-manganese complexes, comparing catalytic ROS scavenging properties and cytoprotective activities. The compounds vary widely in ability to scavenge hydrogen peroxide, with this activity most influenced by salen ring alkoxy substitution and aromatic bridge modifications. In contrast, all compounds show comparable SOD activities. The most active alkoxy-substituted catalase mimetics protected cultured cells from hydrogen peroxide, and a subset of these were also neuroprotective in a rodent stroke model. Thus, structural modification of the prototype EUK-8 yields compounds with enhanced catalase activity and, in turn, biological effectiveness. This supports the concept that salen-manganese complexes represent a class of SOD and, in particular, catalase mimetics potentially useful against ROS-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12238934     DOI: 10.1021/jm020207y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  54 in total

1.  Stability, disposition, and penetration of catalytic antioxidants Mn-porphyrin and Mn-salen and of methylprednisolone in spinal cord injury.

Authors:  Liqin Wu; Yichu Shan; Danxia Liu
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-06

2.  Dentofacial parameters explaining variability in retroclination of the maxillary central incisors.

Authors:  Bernd G Lapatki; Andreas Klatt; Jürgen Schulte-Mönting; Irmtrud E Jonas
Journal:  J Orofac Orthop       Date:  2007-03       Impact factor: 1.938

Review 3.  Texaphyrins: tumor localizing redox active expanded porphyrins.

Authors:  Jonathan F Arambula; Christian Preihs; Derric Borthwick; Darren Magda; Jonathan L Sessler
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

4.  MnTBAP or Catalase Is More Protective against Oxidative Stress in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia than Their Co-Administration (EUK-134).

Authors:  Michelle Quan; Charles L Cai; Gloria B Valencia; Jacob V Aranda; Kay D Beharry
Journal:  React Oxyg Species (Apex)       Date:  2017-01-01

5.  Physical properties, ligand substitution reactions, and biological activity of Co(iii)-Schiff base complexes.

Authors:  A Paden King; Hendryck A Gellineau; Samantha N MacMillan; Justin J Wilson
Journal:  Dalton Trans       Date:  2019-05-07       Impact factor: 4.390

Review 6.  Radioprotection of normal tissue cells.

Authors:  Patrick Maier; Frederik Wenz; Carsten Herskind
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

Review 7.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

8.  Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.

Authors:  Ines Batinić-Haberle; Michael M Ndengele; Salvatore Cuzzocrea; Júlio S Rebouças; Ivan Spasojević; Daniela Salvemini
Journal:  Free Radic Biol Med       Date:  2008-10-17       Impact factor: 7.376

9.  Unexpected Assembly of a Novel Triply Bridged Diiron(II) Core by a Bidentate Schiff Base Ligand.

Authors:  Aubrey L Smith; Cynthia S Day; Lawrence Que; Yuming Zhou; Ulrich Bierbach
Journal:  Inorganica Chim Acta       Date:  2007-05-01       Impact factor: 2.545

Review 10.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities.

Authors:  Georg T Wondrak
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.